Post by IXICO

Thank you to everyone who came to visit us at our poster! It was great to see you all. Here’s Robin Wolz, Chief Scientific and Medical Officer and Mihyun Waugh, PhD, Senior Biomarker Scientist, talking with the HAI community about our latest work. 📌 Poster ID#71 Title: ID Agreement Between Amyloid Status Prediction from Visual Read, SUVR Thresholding, and AI-Based Interpretation of Amyloid PET 📍 Presented by Jane Waugh, Senior Biomarker Scientist at IXICO Key Insight: SUVR and AI both align strongly with expert reads—but misclassify different borderline cases. This means they capture complementary information. Combining these methods can boost confidence, reduce variability, and streamline trial workflows. ✅ Why it matters: More consistent participant selection Greater confidence in trial outcomes Improved operational efficiency 📈 Next Steps: IXICO is integrating AI with SUVR to deliver standardised, quantitative decision-support for amyloid PET interpretation. If you’re around at HAI 2025, let’s meet! https://lnkd.in/e2JcaF_J